SlideShare a Scribd company logo
Process improvement delivered by a
high efficiency, automated single cell
cloning system
Andrea Gough*, Erika Parkinson, Ian Taylor, Solentim Limited, UK.
Andrea.Gough@solentim.com
*First author
Abstract
Single cell cloning (SCC) and associated cloning efficiency
(colony outgrowth) is currently regarded as an important
and discrete step in stable cell line development and cell
engineering. Even with improved targeted gene editing
like CRISPR/Cas9, many hundreds of single cell clones still
need to be created and analyzed.
For many laboratories, flow cytometry (FACS) or limiting
dilution (LD) is the current method of choice for single
cell deposition, however, each method has its drawbacks.
When using FACS, very high seeding efficiency results
can be achieved but often at the expense of cell survival
and growth due to the harsh treatment of the cells during
processing.WhenusingLD,thereverseisthecase;whereby
good cell survival can be achieved but at low seeding
efficiencies. These intrinsic inefficiencies often result in
a combination of the two processes being implemented
and used on a case by case basis; FACS for robust cell
lines and LD for sensitive cell lines. In addition to these
drawbacks, neither of these processes offer independent
confirmation of the single cell deposition.
In this poster, we introduce a new dedicated SCC platform
called Verified In-Situ Plate Seeding (or VIPS™), which
combines gentle single cell deposition with concurrent
in-situ image verification of the single cell in a well. VIPS
uses a proprietary process of SMART™ LD whereby the cell
droplet is imaged immediately on dispensing in the well to
confirm presence or absence of a single cell (see figure 2).
Introduction
Previous technology
developed by Solentim
successfully addressed
the issue of verifying
clonality and colony
outgrowth monitoring
in cell line development.
However, there remains
a bottleneck upstream
of this - the efficient
dispensing of single cells. The VIPS represents a unique
approach to single cell dispensing:
•	 Simple to use
•	 Gentle (low pressure) on cells therefore applicable to a
wide range of cell lines
•	 Uses statistically accepted distribution models
•	 Less labour intensive
•	 Improves seeding efficiencies
•	 Enhanced clonality report and evidence gathering
•	 Fluorescence option for validation
The VIPS™ system is a small bench top instrument that is
placed within a standard biological safety cabinet (class II)
for sterility (see figure 1) with all tubing and components
that come into contact with cells easily sterilised or
replaced. This avoids reliance on expensive proprietary
consumable supplies.
The system dispenses a single droplet into an empty well
followed by immediate imaging of the droplet. If a cell
was deposited, the well will be filled with media. If a cell
was not detected, the system will deposit another drop
to the side and image the position again (see figure 3).
The system uses a stack of images to assess the presence
of a cell and this will take place a maximum of 16 times
to effectively ‘re-use’ any empty wells and increase the
frequency of single cell wells.
Figure 2: Flow diagram representation of the VIPS workflow.
Solentim Ltd
VIPS and SMART LD are a trademarks of Solentim.
Other brands or product names are trademarks of their respective holders.
© Copyright 2018 Solentim Ltd. All rights reserved.
Results are reported in real time so that the user can see
which wells have been populated, and this achieves the
entire dispensing of a 96 well plate in approximately 10
minutes (dependent upon the cell density being used).
All together the VIPS efficiently improves the process
of clonal cell line development by combining droplet
imaging, single cell verification, outgrowth assessment
and seeding validation using FL capabilities.
Methods and materials
Five cell lines were tested for seeding and cloning
efficiency using the VIPS:
•	 2x CHOZN® pools (supplied by Millipore Sigma, St Louis,
USA)
•	 DLD-1 (adherent colon adenocarcinoma)
•	 HCT116 (adherent colorectal carcinoma)
•	 THP-1 (suspension monocyte-like cell line)
Cell lines were grown as per manufacturers instructions.
The CHOZN pools were grown in AC free conditions.
Cells were diluted to 18,000 cells/ml and seeded to 96well
plates using the VIPS. Plates were then imaged by the
CellMetric (brightfield) on days 0, 2, 7 and 10 to assess
outgrowth. HCT116, DLD-1 and THP-1 were also cloned
by limiting dilution for comparison.
Results and discussion
CHOZN pool
seeding and
outgrowth data
Seeding efficiencies for
both pools resulted in an
average of 52% of wells
containing a single cell
(see figure 4).
Clonal outgrowth for
the two pools was an
average of 75% and 62%
(see figure 5) compared
to 30-50% and 60-
70% respectively using their normal limiting dilutions
approach (results not shown).
Figure 6 displays a specific example from a plate seeded
withaCHOZNpool. 85%ofwellswereconfirmedtohavea
single cell at the time of seeding (green wells). Outgrowth
monitoring revealed 65% of these cells divided and
formed colonies with a large range in colony size after 13
days (see figure 7). All data is available to the user and can
be used to track and monitor cell growth from the moment
the cell is dispensed into a well.
SystemValidation
In addition to the brightfield ca-
pabilities to monitor colony out-
growth, the VIPS has fluorescent
imaging capability. Utilising fluo-
rescent cells the VIPS data can be
validated using the QC application
on day 0 using the whole well im-
age. In this case outgrowth is not
necessary for results saving the
user time and money.
Presented at: CCE – XVI Conference, Tampa, May 2018
DISPENSE
Small cell droplet
deposited into
empty well
Under low pressure
Continual cell agitation
96 well plate
DETECT
Image droplet
BF standard imaging
Fluorescence imaging for
qualification
CONFIRM
Image feedback loop
No cell = Repeat cell
droplet
Cell present = Media fill
Figure 1: VIPS System location in
biological safety cabinet (class II).
Figure 3: Three images captured of a well being processed by the VIPS
during a seeding run. A) An empty well before dispensing. B) The same
well with a single drop deposited – highlighted by an arrow in the image.
C) The same well after cell detection; the well is
filled with the media.
2. AFTER
DISPENSING
3. MEDIA
FILLING
1. BEFORE
DISPENSING
Figure 4: Average seeding results
obtained by dispensing two CHOZN
pools using the VIPS system into
7 x 96 well plates per pool.
Pool 1 Pool 2
0
20
40
60
Percentage%
Average Seeding Efficiency
P1 P2 P3 P4 P5 P6 P7
0
10
20
30
40
50
60
70
80
90
Percentage(%)
Cloning Efficiency Average Cloning Efficiency
P1 P2 P3 P4 P5 P6 P7
Cloning efficiency
A) CHOZN pool 1
B) CHOZN pool 2
Figure 5: Outgrowth results obtained by dispensing two CHOZN pools using
the VIPS system into 7 x 96 well plates per pool. The orange line indicates the
average cloning efficiency obtained across the seven plates for each pool.
Figure 7: Left image – well B8. Right image - well D10. Growth Rate graph
displaying the growth rate as determined using whole well confluence %.
The whole well image and the confluence readings highlight the difference
in clonal growth between single seeded cells.
Hour 2 Day 2 Day7 Day 9 Day 13
0.00
5.00
10.00
15.00
20.00
Confluence%
B8 D10
Figure 9:
Well output
verifying the
presence on of
a single cell, a
well containing
multiple cells
and a well
containing no
cells using the
fluorescence
imaging
capabilities
of the VIPS.
Figure 8: Graphical representation of the improvement achieved when
using the VIPS to seed HCT116, DLD1 and THP1 cell lines compared to
standard limiting dilution. Data is shown as number of clonal colonies
produced with VIPS and limiting dilution for each cell line and the
resulting percentage increase using VIPS over limiting dilution.
HCT116 DLD1 THP1
0
5
10
15
20
25
30
35
LD- Average # Clonal Growth VIPS - Average # Clonal Growth
Averagenumberofclonalcolonies
per96wellplate
increase in the production of clonally derived colonies
using VIPS vs limiting dilution for alternative cell lines
Figure 6: Software output
from VIPS seeding results
(left image) and whole well
imaging (right image) of
a 96 well plate at point of
seeding and at 13 days post
seeding to show colony
growth. The images captured
of well D8 are also displayed
at each time point to show
the tracking of a single cell
into a colony and how the
software can report this data.
Figure 10:
Enhanced
clonality report
displaying the
VIPS drop image
containing
evidence of
the single cell
combined with a
whole well image,
taken at day 8,
containing the
growing clone a
single or multiple
whole well images
at selected time
points can be
included in
the report.
Figure 11: A) Cell reservoir. B) Media tubing. Both made from materials
suitable for sterilisation and provided as consumables if required.
HCT116, DLD-1 andTHP-1 cell line data
Cell line development and the requirement to dispense
a single cell is required for many applications. To
demonstrate the versatility and sensitivity of the VIPS,
three additional cell lines were seeded using the VIPS and
outgrowth monitored.
For all the cell lines dispensed we saw a marked increase
in the number of clonal colonies achieved per plate with
VIPS seeding vs standard limiting dilution (see figure 8).
Enhanced Clonality Report
The VIPS system generates an enhanced clonality report
that will include the drop image containing the single cell
andsubsequentwholewellimagesofthecolonyoutgrowth
(see figure 10). This report is time and date stamped and
can be produced as a PDF or PowerPoint.
Consumables
TheVIPSsystemoffersuserstheoptiontoeliminatetheneed
for expensive proprietary consumables (see figure 11), the
only parts that come into contact with the cell culture and
media are the cell reservoir and media tubing. Both can be
sterilised and re-used if required and Solentim can provide
thesepartsasconsumables.AlternativelyCellReservoirsand
tubing can be provide as“Project Kits”and treated as single-
use disposables
The data presented here show that the VIPS improves
the cloning and outgrowth efficiency of cell lines
not just for therapeutics but potentially across many
other applications, when compared to FACS and
limiting dilution. Integrating this system into a cell line
development laboratory will provide increased output of
clonesforassessment,clonalityassuranceandsupporting
documentation.

More Related Content

What's hot

Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
Merck Life Sciences
 
Promises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
Promises and Challenges of Manufacturing and Testing Viral Producer Cell LinesPromises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
Promises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
Merck Life Sciences
 
Presentation by Systimunne - at the Cell Line Development & Engineering Summi...
Presentation by Systimunne - at the Cell Line Development & Engineering Summi...Presentation by Systimunne - at the Cell Line Development & Engineering Summi...
Presentation by Systimunne - at the Cell Line Development & Engineering Summi...
IanTaylor50
 
Nicheoutsourcing
NicheoutsourcingNicheoutsourcing
Nicheoutsourcing
SMEbiotech
 
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
Merck Life Sciences
 
Does your cell line have a secret? Avoid surprises with characterization
Does your cell line have a secret? Avoid surprises with characterizationDoes your cell line have a secret? Avoid surprises with characterization
Does your cell line have a secret? Avoid surprises with characterization
Merck Life Sciences
 
Virus Safety in Vaccine Production
Virus Safety in Vaccine ProductionVirus Safety in Vaccine Production
Virus Safety in Vaccine Production
Dr. Priyabrata Pattnaik
 
Biosafety Testing Solutions for Cell & Gene Therapy
Biosafety Testing Solutions for Cell & Gene TherapyBiosafety Testing Solutions for Cell & Gene Therapy
Biosafety Testing Solutions for Cell & Gene Therapy
Merck Life Sciences
 
Valitacell Technology
Valitacell TechnologyValitacell Technology
Valitacell Technology
Carolanne Doherty, Ph.D
 
Production and purification of Viral vectors for gene and cell therapy appli...
Production and purification of  Viral vectors for gene and cell therapy appli...Production and purification of  Viral vectors for gene and cell therapy appli...
Production and purification of Viral vectors for gene and cell therapy appli...
Dr. Priyabrata Pattnaik
 
Platform Technologies to Accelerate Novel Vaccine Development and Manufacturing
Platform Technologies to Accelerate Novel Vaccine Development and ManufacturingPlatform Technologies to Accelerate Novel Vaccine Development and Manufacturing
Platform Technologies to Accelerate Novel Vaccine Development and Manufacturing
Merck Life Sciences
 
Use of rapid quality control test methods as alternatives to traditional meth...
Use of rapid quality control test methods as alternatives to traditional meth...Use of rapid quality control test methods as alternatives to traditional meth...
Use of rapid quality control test methods as alternatives to traditional meth...
Merck Life Sciences
 
Alkemists - Analytical Services Triad
Alkemists - Analytical Services TriadAlkemists - Analytical Services Triad
Alkemists - Analytical Services Triad
AlkemistsLabs
 
Addressing the Challenge of Scalability in Viral Vectors
Addressing the Challenge of Scalability in Viral VectorsAddressing the Challenge of Scalability in Viral Vectors
Addressing the Challenge of Scalability in Viral Vectors
MilliporeSigma
 

What's hot (15)

Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
 
Promises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
Promises and Challenges of Manufacturing and Testing Viral Producer Cell LinesPromises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
Promises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
 
Presentation by Systimunne - at the Cell Line Development & Engineering Summi...
Presentation by Systimunne - at the Cell Line Development & Engineering Summi...Presentation by Systimunne - at the Cell Line Development & Engineering Summi...
Presentation by Systimunne - at the Cell Line Development & Engineering Summi...
 
Cell bank maintenence
Cell bank maintenenceCell bank maintenence
Cell bank maintenence
 
Nicheoutsourcing
NicheoutsourcingNicheoutsourcing
Nicheoutsourcing
 
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
 
Does your cell line have a secret? Avoid surprises with characterization
Does your cell line have a secret? Avoid surprises with characterizationDoes your cell line have a secret? Avoid surprises with characterization
Does your cell line have a secret? Avoid surprises with characterization
 
Virus Safety in Vaccine Production
Virus Safety in Vaccine ProductionVirus Safety in Vaccine Production
Virus Safety in Vaccine Production
 
Biosafety Testing Solutions for Cell & Gene Therapy
Biosafety Testing Solutions for Cell & Gene TherapyBiosafety Testing Solutions for Cell & Gene Therapy
Biosafety Testing Solutions for Cell & Gene Therapy
 
Valitacell Technology
Valitacell TechnologyValitacell Technology
Valitacell Technology
 
Production and purification of Viral vectors for gene and cell therapy appli...
Production and purification of  Viral vectors for gene and cell therapy appli...Production and purification of  Viral vectors for gene and cell therapy appli...
Production and purification of Viral vectors for gene and cell therapy appli...
 
Platform Technologies to Accelerate Novel Vaccine Development and Manufacturing
Platform Technologies to Accelerate Novel Vaccine Development and ManufacturingPlatform Technologies to Accelerate Novel Vaccine Development and Manufacturing
Platform Technologies to Accelerate Novel Vaccine Development and Manufacturing
 
Use of rapid quality control test methods as alternatives to traditional meth...
Use of rapid quality control test methods as alternatives to traditional meth...Use of rapid quality control test methods as alternatives to traditional meth...
Use of rapid quality control test methods as alternatives to traditional meth...
 
Alkemists - Analytical Services Triad
Alkemists - Analytical Services TriadAlkemists - Analytical Services Triad
Alkemists - Analytical Services Triad
 
Addressing the Challenge of Scalability in Viral Vectors
Addressing the Challenge of Scalability in Viral VectorsAddressing the Challenge of Scalability in Viral Vectors
Addressing the Challenge of Scalability in Viral Vectors
 

Similar to Process improvement delivered by a high efficiency, automated single cell cloning system

ESACT 2017 Poster - A new cell line development platform for sigh efficiency ...
ESACT 2017 Poster - A new cell line development platform for sigh efficiency ...ESACT 2017 Poster - A new cell line development platform for sigh efficiency ...
ESACT 2017 Poster - A new cell line development platform for sigh efficiency ...
IanTaylor50
 
ESACT poster_2015 - Melisa Carpio, Takeda
ESACT poster_2015 - Melisa Carpio, TakedaESACT poster_2015 - Melisa Carpio, Takeda
ESACT poster_2015 - Melisa Carpio, Takeda
IanTaylor50
 
Poster presentation - Documented Clonality Report for Regulatory Submission
Poster presentation - Documented Clonality Report for Regulatory SubmissionPoster presentation - Documented Clonality Report for Regulatory Submission
Poster presentation - Documented Clonality Report for Regulatory Submission
IanTaylor50
 
A microfluidic platform for complete mammalian cell culture
A microfluidic platform for complete mammalian cell cultureA microfluidic platform for complete mammalian cell culture
A microfluidic platform for complete mammalian cell cultureAlfonso Enrique Islas Rodríguez
 
Fujifilm Diosynth poster from 13th PEACe Conference, Valencia, Spain
Fujifilm Diosynth poster from 13th PEACe Conference, Valencia, SpainFujifilm Diosynth poster from 13th PEACe Conference, Valencia, Spain
Fujifilm Diosynth poster from 13th PEACe Conference, Valencia, Spain
IanTaylor50
 
VERO Bioreactor Cell Culture and Vaccine Production 4TR1- Capstone Project
VERO Bioreactor Cell Culture and Vaccine Production 4TR1- Capstone ProjectVERO Bioreactor Cell Culture and Vaccine Production 4TR1- Capstone Project
VERO Bioreactor Cell Culture and Vaccine Production 4TR1- Capstone ProjectYang Liu
 
Scale up in Tissue Eng
Scale up in Tissue EngScale up in Tissue Eng
Scale up in Tissue Eng
Vijay Raj Yanamala
 
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
KBI Biopharma
 
Array_nmeth.3507
Array_nmeth.3507Array_nmeth.3507
Array_nmeth.3507Aana Hahn
 
CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...
CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...
CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...
IanTaylor50
 
Measurement of microbial growth
Measurement of microbial growthMeasurement of microbial growth
Measurement of microbial growth
NOOR ARSHIA
 
Building 3D Tissues for Transplantation and Drug Screening
Building 3D Tissues for Transplantation and Drug ScreeningBuilding 3D Tissues for Transplantation and Drug Screening
Building 3D Tissues for Transplantation and Drug Screening
Melanie Matheu
 
SAFC Customer Poster - PEACe Conference 2015
SAFC Customer Poster - PEACe Conference 2015SAFC Customer Poster - PEACe Conference 2015
SAFC Customer Poster - PEACe Conference 2015
IanTaylor50
 
Cord Blood Separation League Table
Cord Blood Separation League TableCord Blood Separation League Table
Cord Blood Separation League Table
Ankita-rastogi
 
Comparison on Techniques of Cell Seperation
Comparison on Techniques of Cell SeperationComparison on Techniques of Cell Seperation
Comparison on Techniques of Cell Seperation
Sararajputsa
 
Methods of measuring microbial growth
Methods of measuring microbial growthMethods of measuring microbial growth
Methods of measuring microbial growth
Abdul Rehman
 
Measuring of migration of a fully automated imaging based approach
Measuring of migration of a fully automated imaging based approachMeasuring of migration of a fully automated imaging based approach
Measuring of migration of a fully automated imaging based approachPerkinElmer, Inc.
 
Ash 2010 poster
Ash 2010 posterAsh 2010 poster
Ash 2010 poster
Teresa Martin
 
Hema I Chapter 8_Diff.ppt
Hema I Chapter 8_Diff.pptHema I Chapter 8_Diff.ppt
Hema I Chapter 8_Diff.ppt
deribew genetu
 
Cimetta et al., 2013
Cimetta et al., 2013Cimetta et al., 2013
Cimetta et al., 2013
Fran Flores
 

Similar to Process improvement delivered by a high efficiency, automated single cell cloning system (20)

ESACT 2017 Poster - A new cell line development platform for sigh efficiency ...
ESACT 2017 Poster - A new cell line development platform for sigh efficiency ...ESACT 2017 Poster - A new cell line development platform for sigh efficiency ...
ESACT 2017 Poster - A new cell line development platform for sigh efficiency ...
 
ESACT poster_2015 - Melisa Carpio, Takeda
ESACT poster_2015 - Melisa Carpio, TakedaESACT poster_2015 - Melisa Carpio, Takeda
ESACT poster_2015 - Melisa Carpio, Takeda
 
Poster presentation - Documented Clonality Report for Regulatory Submission
Poster presentation - Documented Clonality Report for Regulatory SubmissionPoster presentation - Documented Clonality Report for Regulatory Submission
Poster presentation - Documented Clonality Report for Regulatory Submission
 
A microfluidic platform for complete mammalian cell culture
A microfluidic platform for complete mammalian cell cultureA microfluidic platform for complete mammalian cell culture
A microfluidic platform for complete mammalian cell culture
 
Fujifilm Diosynth poster from 13th PEACe Conference, Valencia, Spain
Fujifilm Diosynth poster from 13th PEACe Conference, Valencia, SpainFujifilm Diosynth poster from 13th PEACe Conference, Valencia, Spain
Fujifilm Diosynth poster from 13th PEACe Conference, Valencia, Spain
 
VERO Bioreactor Cell Culture and Vaccine Production 4TR1- Capstone Project
VERO Bioreactor Cell Culture and Vaccine Production 4TR1- Capstone ProjectVERO Bioreactor Cell Culture and Vaccine Production 4TR1- Capstone Project
VERO Bioreactor Cell Culture and Vaccine Production 4TR1- Capstone Project
 
Scale up in Tissue Eng
Scale up in Tissue EngScale up in Tissue Eng
Scale up in Tissue Eng
 
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
 
Array_nmeth.3507
Array_nmeth.3507Array_nmeth.3507
Array_nmeth.3507
 
CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...
CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...
CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...
 
Measurement of microbial growth
Measurement of microbial growthMeasurement of microbial growth
Measurement of microbial growth
 
Building 3D Tissues for Transplantation and Drug Screening
Building 3D Tissues for Transplantation and Drug ScreeningBuilding 3D Tissues for Transplantation and Drug Screening
Building 3D Tissues for Transplantation and Drug Screening
 
SAFC Customer Poster - PEACe Conference 2015
SAFC Customer Poster - PEACe Conference 2015SAFC Customer Poster - PEACe Conference 2015
SAFC Customer Poster - PEACe Conference 2015
 
Cord Blood Separation League Table
Cord Blood Separation League TableCord Blood Separation League Table
Cord Blood Separation League Table
 
Comparison on Techniques of Cell Seperation
Comparison on Techniques of Cell SeperationComparison on Techniques of Cell Seperation
Comparison on Techniques of Cell Seperation
 
Methods of measuring microbial growth
Methods of measuring microbial growthMethods of measuring microbial growth
Methods of measuring microbial growth
 
Measuring of migration of a fully automated imaging based approach
Measuring of migration of a fully automated imaging based approachMeasuring of migration of a fully automated imaging based approach
Measuring of migration of a fully automated imaging based approach
 
Ash 2010 poster
Ash 2010 posterAsh 2010 poster
Ash 2010 poster
 
Hema I Chapter 8_Diff.ppt
Hema I Chapter 8_Diff.pptHema I Chapter 8_Diff.ppt
Hema I Chapter 8_Diff.ppt
 
Cimetta et al., 2013
Cimetta et al., 2013Cimetta et al., 2013
Cimetta et al., 2013
 

More from IanTaylor50

Joel welch.pdf (amsterdam, april 2017)
Joel welch.pdf (amsterdam, april 2017)Joel welch.pdf (amsterdam, april 2017)
Joel welch.pdf (amsterdam, april 2017)
IanTaylor50
 
Rachel novak (casss forum, wahington dc, jan 2017)
Rachel novak (casss forum, wahington dc,  jan 2017)Rachel novak (casss forum, wahington dc,  jan 2017)
Rachel novak (casss forum, wahington dc, jan 2017)
IanTaylor50
 
Thomas Sterovsky - Polymun Scientific (Vienna Conference, April 2016)
Thomas Sterovsky - Polymun Scientific (Vienna Conference, April 2016)Thomas Sterovsky - Polymun Scientific (Vienna Conference, April 2016)
Thomas Sterovsky - Polymun Scientific (Vienna Conference, April 2016)
IanTaylor50
 
Arna Andrews, CSL limited (vienna, april 2016)
Arna Andrews,  CSL limited (vienna, april 2016)Arna Andrews,  CSL limited (vienna, april 2016)
Arna Andrews, CSL limited (vienna, april 2016)
IanTaylor50
 
Clonality report for cell metric customer launch
Clonality report for cell metric   customer launchClonality report for cell metric   customer launch
Clonality report for cell metric customer launch
IanTaylor50
 
Assessment of clonality for production cell lines via high resolution imaging
Assessment of clonality for production cell lines via high resolution imagingAssessment of clonality for production cell lines via high resolution imaging
Assessment of clonality for production cell lines via high resolution imaging
IanTaylor50
 
US Pharma presentation on clone screen strategy for monoclonality using Solen...
US Pharma presentation on clone screen strategy for monoclonality using Solen...US Pharma presentation on clone screen strategy for monoclonality using Solen...
US Pharma presentation on clone screen strategy for monoclonality using Solen...
IanTaylor50
 

More from IanTaylor50 (7)

Joel welch.pdf (amsterdam, april 2017)
Joel welch.pdf (amsterdam, april 2017)Joel welch.pdf (amsterdam, april 2017)
Joel welch.pdf (amsterdam, april 2017)
 
Rachel novak (casss forum, wahington dc, jan 2017)
Rachel novak (casss forum, wahington dc,  jan 2017)Rachel novak (casss forum, wahington dc,  jan 2017)
Rachel novak (casss forum, wahington dc, jan 2017)
 
Thomas Sterovsky - Polymun Scientific (Vienna Conference, April 2016)
Thomas Sterovsky - Polymun Scientific (Vienna Conference, April 2016)Thomas Sterovsky - Polymun Scientific (Vienna Conference, April 2016)
Thomas Sterovsky - Polymun Scientific (Vienna Conference, April 2016)
 
Arna Andrews, CSL limited (vienna, april 2016)
Arna Andrews,  CSL limited (vienna, april 2016)Arna Andrews,  CSL limited (vienna, april 2016)
Arna Andrews, CSL limited (vienna, april 2016)
 
Clonality report for cell metric customer launch
Clonality report for cell metric   customer launchClonality report for cell metric   customer launch
Clonality report for cell metric customer launch
 
Assessment of clonality for production cell lines via high resolution imaging
Assessment of clonality for production cell lines via high resolution imagingAssessment of clonality for production cell lines via high resolution imaging
Assessment of clonality for production cell lines via high resolution imaging
 
US Pharma presentation on clone screen strategy for monoclonality using Solen...
US Pharma presentation on clone screen strategy for monoclonality using Solen...US Pharma presentation on clone screen strategy for monoclonality using Solen...
US Pharma presentation on clone screen strategy for monoclonality using Solen...
 

Recently uploaded

Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
NathanBaughman3
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
kumarmathi863
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
DiyaBiswas10
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Sérgio Sacani
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
muralinath2
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
Areesha Ahmad
 
Citrus Greening Disease and its Management
Citrus Greening Disease and its ManagementCitrus Greening Disease and its Management
Citrus Greening Disease and its Management
subedisuryaofficial
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
muralinath2
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
Sérgio Sacani
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SELF-EXPLANATORY
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
muralinath2
 
justice-and-fairness-ethics with example
justice-and-fairness-ethics with examplejustice-and-fairness-ethics with example
justice-and-fairness-ethics with example
azzyixes
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
ChetanK57
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
muralinath2
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
AADYARAJPANDEY1
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
muralinath2
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
sachin783648
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
Areesha Ahmad
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
Richard Gill
 

Recently uploaded (20)

Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
 
Citrus Greening Disease and its Management
Citrus Greening Disease and its ManagementCitrus Greening Disease and its Management
Citrus Greening Disease and its Management
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
 
justice-and-fairness-ethics with example
justice-and-fairness-ethics with examplejustice-and-fairness-ethics with example
justice-and-fairness-ethics with example
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
 

Process improvement delivered by a high efficiency, automated single cell cloning system

  • 1. Process improvement delivered by a high efficiency, automated single cell cloning system Andrea Gough*, Erika Parkinson, Ian Taylor, Solentim Limited, UK. Andrea.Gough@solentim.com *First author Abstract Single cell cloning (SCC) and associated cloning efficiency (colony outgrowth) is currently regarded as an important and discrete step in stable cell line development and cell engineering. Even with improved targeted gene editing like CRISPR/Cas9, many hundreds of single cell clones still need to be created and analyzed. For many laboratories, flow cytometry (FACS) or limiting dilution (LD) is the current method of choice for single cell deposition, however, each method has its drawbacks. When using FACS, very high seeding efficiency results can be achieved but often at the expense of cell survival and growth due to the harsh treatment of the cells during processing.WhenusingLD,thereverseisthecase;whereby good cell survival can be achieved but at low seeding efficiencies. These intrinsic inefficiencies often result in a combination of the two processes being implemented and used on a case by case basis; FACS for robust cell lines and LD for sensitive cell lines. In addition to these drawbacks, neither of these processes offer independent confirmation of the single cell deposition. In this poster, we introduce a new dedicated SCC platform called Verified In-Situ Plate Seeding (or VIPS™), which combines gentle single cell deposition with concurrent in-situ image verification of the single cell in a well. VIPS uses a proprietary process of SMART™ LD whereby the cell droplet is imaged immediately on dispensing in the well to confirm presence or absence of a single cell (see figure 2). Introduction Previous technology developed by Solentim successfully addressed the issue of verifying clonality and colony outgrowth monitoring in cell line development. However, there remains a bottleneck upstream of this - the efficient dispensing of single cells. The VIPS represents a unique approach to single cell dispensing: • Simple to use • Gentle (low pressure) on cells therefore applicable to a wide range of cell lines • Uses statistically accepted distribution models • Less labour intensive • Improves seeding efficiencies • Enhanced clonality report and evidence gathering • Fluorescence option for validation The VIPS™ system is a small bench top instrument that is placed within a standard biological safety cabinet (class II) for sterility (see figure 1) with all tubing and components that come into contact with cells easily sterilised or replaced. This avoids reliance on expensive proprietary consumable supplies. The system dispenses a single droplet into an empty well followed by immediate imaging of the droplet. If a cell was deposited, the well will be filled with media. If a cell was not detected, the system will deposit another drop to the side and image the position again (see figure 3). The system uses a stack of images to assess the presence of a cell and this will take place a maximum of 16 times to effectively ‘re-use’ any empty wells and increase the frequency of single cell wells. Figure 2: Flow diagram representation of the VIPS workflow. Solentim Ltd VIPS and SMART LD are a trademarks of Solentim. Other brands or product names are trademarks of their respective holders. © Copyright 2018 Solentim Ltd. All rights reserved. Results are reported in real time so that the user can see which wells have been populated, and this achieves the entire dispensing of a 96 well plate in approximately 10 minutes (dependent upon the cell density being used). All together the VIPS efficiently improves the process of clonal cell line development by combining droplet imaging, single cell verification, outgrowth assessment and seeding validation using FL capabilities. Methods and materials Five cell lines were tested for seeding and cloning efficiency using the VIPS: • 2x CHOZN® pools (supplied by Millipore Sigma, St Louis, USA) • DLD-1 (adherent colon adenocarcinoma) • HCT116 (adherent colorectal carcinoma) • THP-1 (suspension monocyte-like cell line) Cell lines were grown as per manufacturers instructions. The CHOZN pools were grown in AC free conditions. Cells were diluted to 18,000 cells/ml and seeded to 96well plates using the VIPS. Plates were then imaged by the CellMetric (brightfield) on days 0, 2, 7 and 10 to assess outgrowth. HCT116, DLD-1 and THP-1 were also cloned by limiting dilution for comparison. Results and discussion CHOZN pool seeding and outgrowth data Seeding efficiencies for both pools resulted in an average of 52% of wells containing a single cell (see figure 4). Clonal outgrowth for the two pools was an average of 75% and 62% (see figure 5) compared to 30-50% and 60- 70% respectively using their normal limiting dilutions approach (results not shown). Figure 6 displays a specific example from a plate seeded withaCHOZNpool. 85%ofwellswereconfirmedtohavea single cell at the time of seeding (green wells). Outgrowth monitoring revealed 65% of these cells divided and formed colonies with a large range in colony size after 13 days (see figure 7). All data is available to the user and can be used to track and monitor cell growth from the moment the cell is dispensed into a well. SystemValidation In addition to the brightfield ca- pabilities to monitor colony out- growth, the VIPS has fluorescent imaging capability. Utilising fluo- rescent cells the VIPS data can be validated using the QC application on day 0 using the whole well im- age. In this case outgrowth is not necessary for results saving the user time and money. Presented at: CCE – XVI Conference, Tampa, May 2018 DISPENSE Small cell droplet deposited into empty well Under low pressure Continual cell agitation 96 well plate DETECT Image droplet BF standard imaging Fluorescence imaging for qualification CONFIRM Image feedback loop No cell = Repeat cell droplet Cell present = Media fill Figure 1: VIPS System location in biological safety cabinet (class II). Figure 3: Three images captured of a well being processed by the VIPS during a seeding run. A) An empty well before dispensing. B) The same well with a single drop deposited – highlighted by an arrow in the image. C) The same well after cell detection; the well is filled with the media. 2. AFTER DISPENSING 3. MEDIA FILLING 1. BEFORE DISPENSING Figure 4: Average seeding results obtained by dispensing two CHOZN pools using the VIPS system into 7 x 96 well plates per pool. Pool 1 Pool 2 0 20 40 60 Percentage% Average Seeding Efficiency P1 P2 P3 P4 P5 P6 P7 0 10 20 30 40 50 60 70 80 90 Percentage(%) Cloning Efficiency Average Cloning Efficiency P1 P2 P3 P4 P5 P6 P7 Cloning efficiency A) CHOZN pool 1 B) CHOZN pool 2 Figure 5: Outgrowth results obtained by dispensing two CHOZN pools using the VIPS system into 7 x 96 well plates per pool. The orange line indicates the average cloning efficiency obtained across the seven plates for each pool. Figure 7: Left image – well B8. Right image - well D10. Growth Rate graph displaying the growth rate as determined using whole well confluence %. The whole well image and the confluence readings highlight the difference in clonal growth between single seeded cells. Hour 2 Day 2 Day7 Day 9 Day 13 0.00 5.00 10.00 15.00 20.00 Confluence% B8 D10 Figure 9: Well output verifying the presence on of a single cell, a well containing multiple cells and a well containing no cells using the fluorescence imaging capabilities of the VIPS. Figure 8: Graphical representation of the improvement achieved when using the VIPS to seed HCT116, DLD1 and THP1 cell lines compared to standard limiting dilution. Data is shown as number of clonal colonies produced with VIPS and limiting dilution for each cell line and the resulting percentage increase using VIPS over limiting dilution. HCT116 DLD1 THP1 0 5 10 15 20 25 30 35 LD- Average # Clonal Growth VIPS - Average # Clonal Growth Averagenumberofclonalcolonies per96wellplate increase in the production of clonally derived colonies using VIPS vs limiting dilution for alternative cell lines Figure 6: Software output from VIPS seeding results (left image) and whole well imaging (right image) of a 96 well plate at point of seeding and at 13 days post seeding to show colony growth. The images captured of well D8 are also displayed at each time point to show the tracking of a single cell into a colony and how the software can report this data. Figure 10: Enhanced clonality report displaying the VIPS drop image containing evidence of the single cell combined with a whole well image, taken at day 8, containing the growing clone a single or multiple whole well images at selected time points can be included in the report. Figure 11: A) Cell reservoir. B) Media tubing. Both made from materials suitable for sterilisation and provided as consumables if required. HCT116, DLD-1 andTHP-1 cell line data Cell line development and the requirement to dispense a single cell is required for many applications. To demonstrate the versatility and sensitivity of the VIPS, three additional cell lines were seeded using the VIPS and outgrowth monitored. For all the cell lines dispensed we saw a marked increase in the number of clonal colonies achieved per plate with VIPS seeding vs standard limiting dilution (see figure 8). Enhanced Clonality Report The VIPS system generates an enhanced clonality report that will include the drop image containing the single cell andsubsequentwholewellimagesofthecolonyoutgrowth (see figure 10). This report is time and date stamped and can be produced as a PDF or PowerPoint. Consumables TheVIPSsystemoffersuserstheoptiontoeliminatetheneed for expensive proprietary consumables (see figure 11), the only parts that come into contact with the cell culture and media are the cell reservoir and media tubing. Both can be sterilised and re-used if required and Solentim can provide thesepartsasconsumables.AlternativelyCellReservoirsand tubing can be provide as“Project Kits”and treated as single- use disposables The data presented here show that the VIPS improves the cloning and outgrowth efficiency of cell lines not just for therapeutics but potentially across many other applications, when compared to FACS and limiting dilution. Integrating this system into a cell line development laboratory will provide increased output of clonesforassessment,clonalityassuranceandsupporting documentation.